Cleared Traditional

K931603 - MILLIPORE RT-100 AEROSOL RETENTION FILTER

K931603 is an FDA 510(k) clearance for MILLIPORE RT-100 AEROSOL RETENTION FILTER, manufactured by Sterimatics Co.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 42-day FDA review.

K931603 · Sterimatics Co. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1993
Decision
42d
Days
Class 2
Risk

K931603 is an FDA 510(k) clearance for the MILLIPORE RT-100 AEROSOL RETENTION FILTER. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Sterimatics Co. (Bedford, US). The FDA issued a Cleared decision on May 13, 1993 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Sterimatics Co. devices

FDA 510(k) Submission Details - K931603

510(k) Number K931603 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 01, 1993
Decision Date May 13, 1993
Days to Decision 42 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
98d faster than avg
Panel avg: 140d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 437
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K931603.
PROMENADE
K930947 · Mada Medical Products, Inc. · Jun 1993
VOYAGE
K930949 · Mada Medical Products, Inc. · Jun 1993
SOFT-MIST(TM)
K924649 · Vortran Medical Technology 1, Inc. · May 1993
THAYER HAND HELD M.K.I. HOLDING CHAMBER
K924535 · Thayer Medical Corp. · Mar 1993
DEVILBISS MODEL 5650 PULMO-AIDE
K923888 · Devilbiss Health Care, Inc. · Feb 1993
BETAMIST 2
K923698 · Rantran, Inc. · Feb 1993